86 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Arpc4tm1c(EUCOMM)Wtsi/Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm/Krt14+ B6.Cg-Arpc4tm1c(EUCOMM)Wtsi Krt14tm1(cre)Wbm	abnormal head skin morphology	J:253986
	abnormal keratinocyte differentiation	J:253986
	abnormal skin appearance	J:253986
	abnormal skin physiology	J:253986
	absent sebaceous gland	J:253986
	acanthosis	J:253986
	alopecia	J:253986
	decreased hair follicle number	J:253986
	dermatitis	J:253986
	dry skin	J:253986
	hyperkeratosis	J:253986
	parakeratosis	J:253986
	psoriasis	J:253986
	scaly skin	J:253986
	skin lesions	J:253986
	sparse hair	J:253986
	thick epidermis	J:253986
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr Ctnnb1tm1Mmt/Ctnnb1+ Krt14tm1.1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ	decreased tumor-free survival time	J:199091
	increased hair follicle number	J:199091
	increased salivary gland tumor incidence	J:199091
	increased squamous cell carcinoma incidence	J:199091
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr Krt14tm1.1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * 129S7/SvEvBrd	normal neoplasm	J:199091
Cd151tm2Nki/Cd151tm2Nki Itga3tm1Son/Itga3+ Krt14tm1(cre)Wbm/? FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm	decreased incidence of tumors by chemical induction	J:205736
	decreased keratinocyte proliferation	J:205736
	decreased tumor growth/size	J:205736
Cd151tm2Nki/Cd151tm2Nki Krt14tm1(cre)Wbm/? FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm	abnormal hair follicle morphology	J:205736
	decreased incidence of tumors by chemical induction	J:205736
	decreased keratinocyte proliferation	J:205736
	decreased tumor growth/size	J:205736
	increased keratinocyte migration	J:205736
	thin epidermis	J:205736
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh Tg(Mt1-Hgf)#Lmb/0 involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J	increased incidence of tumors by chemical induction	J:240961
	increased metastatic potential	J:240961
	increased tumor growth/size	J:240961
Ctnnb1tm1Mmt/Ctnnb1+ Krt14tm1.1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * 129X1/SvJ	normal neoplasm	J:199091
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd	decreased gamma-delta T cell number	J:202499
	increased neutrophil cell number	J:202499
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * C57BL/6	abnormal hair growth	J:69463
	alopecia	J:69463
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm Krt14tm1.1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * C57BL/6	abnormal hair growth	J:69463
	alopecia	J:69463
Itga3tm1Son/Itga3tm1Son Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * FVB/N	alopecia	J:145988
	blistering	J:145988
	enhanced wound healing	J:145988
	skin inflammation	J:145988
	thick skin	J:145988
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh either: FVB.129-Pard3tm1Shoh Krt14tm1(cre)Wbm or (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased incidence of tumors by chemical induction	J:192905
	decreased tumor growth/size	J:192905
	decreased tumor latency	J:192905
	increased incidence of tumors by chemical induction	J:192905
	increased metastatic potential	J:192905
	increased tumor growth/size	J:192905
	increased tumor latency	J:192905
	normal neoplasm	J:192905
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J	abnormal epidermal melanocyte morphology	J:240961
	abnormal hair follicle melanocyte morphology	J:240961
	increased incidence of tumors by chemical induction	J:240961
	increased melanocyte number	J:240961
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh Tg(HIST1H2BB/EGFP)1Pa/0 involves: 129 * C57BL/6J	abnormal melanocyte morphology	J:240961
Krt14tm1.1(cre)Wbm/Krt14+ Tg(KRT14-Snai1)1Efu/0 Trp53tm1Brn/Trp53tm1Brn involves: 129P2/OlaHsd * CD-1	increased basal cell carcinoma incidence	J:229072
	increased sebaceous gland tumor incidence	J:229072
	increased skin squamous cell carcinoma incidence	J:229072
	increased skin tumor incidence	J:229072
Wlstm1.1Arte/Wlstm1.1Arte Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * C57BL/6	abnormal adipose tissue physiology	J:202499
	abnormal ear morphology	J:202499
	abnormal eye morphology	J:202499
	abnormal hair growth	J:202499
	abnormal nose morphology	J:202499
	abnormal skin appearance	J:202499
	abnormal skin physiology	J:202499
	abnormal T cell differentiation	J:202499
	abnormal T cell physiology	J:202499
	abnormal T cell subpopulation ratio	J:202499
	cutaneous mastocytosis	J:202499
	decreased body size	J:202499
	decreased body surface temperature	J:202499
	decreased double-positive T cell number	J:202499
	decreased gamma-delta T cell number	J:202499
	decreased hair follicle number	J:202499
	decreased T cell number	J:202499
	decreased thymus weight	J:202499
	epidermal spongiosis	J:202499
	flaky skin	J:202499
	hair follicle degeneration	J:202499
	impaired skin barrier function	J:202499
	increased double-negative T cell number	J:202499
	increased keratinocyte proliferation	J:202499
	increased macrophage cell number	J:202499
	increased neutrophil cell number	J:202499
	increased T cell proliferation	J:202499
	postnatal growth retardation	J:202499
	premature death	J:202499
	reddish skin	J:202499
	scaly skin	J:202499
	skin inflammation	J:202499
	small thymus medulla	J:202499
	sparse hair	J:202499
	thin dermal layer	J:202499
	thin hypodermis	J:202499
	thin skin	J:202499
	thymus atrophy	J:202499
	thymus hypoplasia	J:202499
Zbtb17tm1Cksn/Zbtb17tm1.1Cksn Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	rough coat	J:123966
Zbtb17tm1Cksn/Zbtb17tm1Cksn Krt14tm1(cre)Wbm/Krt14+ involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	abnormal coat/ hair morphology	J:123966
	abnormal epidermal layer morphology	J:123966
	abnormal hair follicle melanocyte morphology	J:123966
	abnormal hair follicle morphology	J:123966
	abnormal hair follicle orientation	J:123966
	darkened coat color	J:123966
	decreased curvature of zigzag hairs	J:123966
	decreased zigzag hair amount	J:123966
	focal dorsal hair loss	J:123966
	hyperkeratosis	J:123966
	increased keratinocyte proliferation	J:123966
	rough coat	J:123966
	sparse hair	J:123966